Lin Shi | Data collection | Best Researcher Award

Dr. Lin Shi | Data collection | Best Researcher Award

Beijing Tiantan Hospital | China

PUBLICATION PROFILE

Orcid

Scopus

🎓 EARLY ACADEMIC PURSUITS

Dr. Lin Shi began her medical education at Harbin Medical University, where she earned both her M.D. and M.M. in Clinical Medicine between 2002 and 2009 under the mentorship of Professor Yunfu Cui. Building on this strong foundation, she pursued a Ph.D. in Neurosurgery at Capital Medical University from 2012 to 2015, under the guidance of Professor Zhongcheng Wang. Her academic background laid the groundwork for a career that would bridge clinical excellence with cutting-edge research in functional neurosurgery.

🩺 PROFESSIONAL ENDEAVORS

Dr. Shi’s clinical and academic career spans over 15 years, with progressive roles in major medical institutions. She started as a neurosurgeon at Beijing Haidian Hospital and soon joined Beijing Tiantan Hospital in 2015, where she advanced from neurosurgeon to attending neurosurgeon and eventually to associate senior neurosurgeon and associate professor by 2019. She also broadened her expertise during a visiting scholar appointment at Stanford University’s Center for Neurological Disorders. Throughout her career, she has taken leadership roles in numerous research projects funded by the National Natural Science Foundation of China and the Beijing Municipal Government, while also serving as an expert reviewer and editorial board member in both national and international scientific communities.

🧠 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Shi has made significant contributions in the field of functional brain disorders, which include conditions such as Parkinson’s disease, epilepsy, dystonia, and other rare neurological disorders. Since 2012, she has worked at the forefront of functional neurosurgery, especially in the areas of deep brain stimulation (DBS) and vagus nerve stimulation. Her research has focused on creating a comprehensive neuromodulation therapy system, including the development of a large-scale clinical database of over 5,000 cases, enabling better analysis and understanding of various brain disorders. She has also led mechanism-based studies on epilepsy, exploring inflammation, neurodegeneration, and neural circuitry using advanced animal models and molecular techniques.

🔬 RESEARCH MILESTONES

Dr. Shi’s research includes landmark studies that have advanced our understanding of epilepsy and DBS therapy. She created reliable animal models of temporal lobe epilepsy and demonstrated that anterior thalamic nucleus (ANT) stimulation offers neuroprotective effects by modulating inflammatory responses and promoting autophagy. At Stanford, she explored the functional connectivity of the brain through electrical stimulation, uncovering links between episodic memory and cortical network architecture—research published in Nature Human Behaviour. She also contributed to the expansion of neuromodulation indications by testing new neural targets and stimulation parameters, which provided key insights into delayed therapeutic responses in movement disorders like Parkinson’s disease.

🏅 IMPACT AND INFLUENCE

Dr. Shi’s influence in neurosurgery and neuroscience is widely recognized. She has led or participated in major research projects supported by the Beijing Natural Science Foundation and the NSFC, and has won numerous awards, including the Mao Yisheng Science and Technology Award and Beijing Youth Science and Technology Award. Her contributions to the development of China’s first domestically approved neurosurgical robot greatly enhanced the accuracy of DBS, reducing surgical error margins from 1.7mm to 0.6mm and enabling safer, faster procedures. The robot system she helped design has now been used in thousands of operations across top hospitals in China, generating significant economic and clinical value.

📚 ACADEMIC CITES AND RECOGNITION

Dr. Shi has authored more than 20 peer-reviewed SCI papers, with a cumulative impact factor exceeding 110. Notable publications include a study in JAMA Neurology (IF 18.3) on evolving intracranial lesions and a collaborative paper in Nature Human Behaviour (IF 13.7) that examined the cognitive effects of brain stimulation. Her research has been cited extensively and has received accolades from leading figures in neuroscience, such as Prof. Christof Koch. Additionally, she serves as a reviewer for several SCI journals and is active in multiple academic committees and expert panels in China.

🧬 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Shi aims to continue pushing the boundaries of neuromodulation therapy. She plans to integrate AI and robotics more deeply into neurosurgical practice, expand the use of DBS in psychiatric and rare neurological diseases, and refine patient-specific treatment algorithms using data from her extensive clinical database. Her vision includes bridging translational neuroscience with real-world application through collaboration with biomedical engineers, AI specialists, and international research institutions. With a strong portfolio of patents, publications, and clinical innovations, Dr. Shi is set to leave a lasting legacy in the treatment of functional brain disorders.

🧾 HONORS, PATENTS, AND GRANT HIGHLIGHTS

Dr. Shi holds five national patents, including devices designed for surgical precision and MRI safety. She has led over five major research projects, including the development of an automated navigation system for DBS and studies on novel neurostimulation targets, with total funding exceeding ¥2 million. Her published work spans top-tier journals such as JAMA Neurology, Brain Stimulation, and CNS Neuroscience & Therapeutics. Recognized as a leading voice in functional neurosurgery, she continues to shape the future of neuroscience in China and beyond.

 📚 TOP NOTES PUBLICATIONS

1. Fronto-parieto-subthalamic activity decodes motor status in Parkinson’s disease
  • Authors: Zhang, Q.; Xie, H.; Zhao, B.; Yin, Z.; Liu, Y.; Liu, D.; Bai, Y.; Zhu, G.; Qin, G.; Gan, Y. et al.

  • Journal: CNS Neuroscience and Therapeutics

  • Year: 2023

2. Pallidal activities during sleep and sleep decoding in dystonia, Huntington’s, and Parkinson’s disease
  • Authors: Yin, Z.; Jiang, Y.; Merk, T.; Neumann, W.-J.; Ma, R.; An, Q.; Bai, Y.; Zhao, B.; Xu, Y.; Fan, H. et al.

  • Journal: Neurobiology of Disease

  • Year: 2023

3. Identification of Cuproptosis Clusters and Integrative Analyses in Parkinson’s Disease
  • Authors: Moxuan Zhang; Wenjia Meng; Chong Liu; Huizhi Wang; Renpeng Li; Qiao Wang; Yuan Gao; Siyu Zhou; Tingting Du; Tianshuo Yuan et al.

  • Journal: Brain Sciences

  • Year: 2023

4. Deep Brain Stimulation Electrode Reconstruction: Comparison between Lead-DBS and Surgical Planning System
  • Authors: Yichen Xu; Guofan Qin; Bojing Tan; Shiying Fan; Qi An; Yuan Gao; Houyou Fan; Hutao Xie; Delong Wu; Huanguang Liu et al.

  • Journal: Journal of Clinical Medicine

  • Year: 2023

5. Comparison of dural puncture and dural incision in deep brain stimulation surgery: A simple but worthwhile technique modification
  • Authors: Fan, S.; Zhang, Q.; Meng, F.; Fang, H.; Yang, G.; Shi, Z.; Liu, H.; Zhang, H.; Yang, A.; Zhang, J. et al.

  • Journal: Frontiers in Neuroscience

  • Year: 2022

Hermona Soreq – molecular neuroscience – Outstanding Scientist Award

Early Academic Pursuits

Prof. Hermona Soreq's academic journey began with a solid foundation in biochemistry and microbiology at The Hebrew University of Jerusalem, where she earned her Bachelor of Science in 1967. She further pursued her Master’s degree at Tel Aviv University, focusing on biochemistry and chemistry teaching, which she completed in 1970. Her academic rigor and passion for molecular studies led her to The Weizmann Institute of Science, where she obtained her PhD in Biochemistry in 1976. Soreq's early career was marked by a prestigious Fogarty Fellowship at Rockefeller University, allowing her to delve into molecular cell biology from 1977 to 1979.

Professional Endeavors

Prof. Hermona Soreq's professional career is distinguished by her long-term association with The Hebrew University of Jerusalem. She joined the faculty in 1986 as the Slesinger Chair of Molecular Neuroscience, a position she has held with distinction. Her roles have included serving as the elected Dean of the Faculty of Mathematics and Natural Sciences from 2005 to 2008, and she is a founding member of the Edmond and Lily Safra Center for Brain Sciences (ELSC). Additionally, Soreq has held prominent positions at the Weizmann Institute and Arizona State University’s Bio-Design Institute, reflecting her international influence and collaborative approach to scientific research.

Contributions and Research Focus

Prof. Hermona Soreq’s research primarily focuses on the complex role of non-coding RNA controllers, particularly microRNAs (miRs) and transfer RNA fragments (tRFs), in brain-to-body functioning. Her groundbreaking work on acetylcholine-related pathways has combined advanced computational neuroscience with cutting-edge technologies such as sequencing, transgenic engineering, and microscopy. This multidisciplinary approach has enabled significant discoveries, including the identification of "CholinomiR" silencers that regulate anxiety, inflammation, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research has also highlighted the impact of these non-coding RNAs on conditions like stroke, epilepsy, and metabolic disorders.

Accolades and Recognition

Prof. Hermona Soreq's contributions to molecular neuroscience have earned her numerous accolades and honors. She has received Honorary PhDs from prestigious institutions including the University of Stockholm, Ben-Gurion University, and Friedrich-Alexander University Erlangen-Nuremberg. Other notable awards include the Teva Founders’ Award, the Lise Meitner Alexander von Humboldt Award, and the Rappaport Prize for Biomedical Research. In 2022, she was awarded the Israeli Prime Minister’s EMET prize in Neuroscience, recognizing her exceptional contributions to the field. Soreq has also been a keynote speaker at major international conferences, further solidifying her status as a leading voice in neuroscience.

Impact and Influence

Throughout her career, Hermona Soreq has had a profound impact on the scientific community, both through her research and her mentorship. She has trained 26 faculty members who have gone on to contribute to various universities worldwide, including institutions in Jerusalem, Tel Aviv, Haifa, the Galilee, Beer Sheva, and internationally in Berkeley, Maryland, Halifax, Ann Arbor, Paris, Tours, Jena, and London. Her research on the cholinergic system’s involvement in stress, neurodegeneration, and metabolic regulation has opened new avenues for understanding and potentially treating these conditions.

Legacy and Future Contributions

Prof. Hermona Soreq’s legacy is characterized by her innovative approach to neuroscience, integrating computational and experimental methods to explore the regulatory roles of non-coding RNAs. Her work has not only advanced scientific knowledge but also has significant implications for therapeutic strategies in treating neurodegenerative and stress-related diseases. As she continues her research, Soreq is poised to make further groundbreaking discoveries that will influence the field for years to come. Her ongoing involvement in academic and scientific advisory boards, including those at Neuro-Cure Center Berlin and the ImmunoSensation Center Bonn, ensures that her expertise will continue to guide and inspire future generations of neuroscientists.

Citations

A total of 34743 citations for his publications, demonstrating the impact and recognition of her research within the academic community.